Magnus Lindh - Infectious Diseases

Author Information

Magnus Lindh is affiliated with the Department of Infectious Diseases at the Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, located in Gothenburg, Sweden. His work primarily focuses on various aspects of infectious diseases, contributing significantly to the understanding and management of these conditions through his research.

Research Contributions

Magnus Lindh has made substantial contributions to the field of infectious diseases, with a particular emphasis on viral infections and their clinical implications. His recent papers cover a range of topics, including the detection of integrated core HBV DNA, the impact of RNA editing on SARS-CoV-2 replication and transmission, and the analysis of SARS-CoV-2-specific T cells. Furthermore, he has contributed to understanding clinical outcomes in cancer patients with COVID-19, the role of CSF biomarkers in COVID-19 patients with neurological symptoms, and the etiology of community-acquired pneumonia in children in Sweden. His research is vital for advancing knowledge on how viral infections interact with the human body and impact public health.

Aliases

Magnus Lindh is also known by other names in academic publications, including M Lindh and M. Lindh. These aliases are used interchangeably in his published works.

Publication and Citation Metrics

Metric	Value
Citation Count	7733
h-index	47
Paper Count	226

Publications:

Alu-PCR design may have compromised detection of integrated core HBV DNA.

DOI: 10.1002/hep.32473

Year: 2022

Impact of ADAR-induced editing of minor viral RNA populations on replication and transmission of SARS-CoV-2

DOI: 10.1073/pnas.2112663119

Year: 2022

Rapid cytokine release assays for analysis of SARS-CoV-2-specific T cells in whole blood

DOI: 10.1093/infdis/jiac005

Year: 2022

Clinical outcomes in cancer patients with COVID-19 in Sweden

DOI: 10.1080/0284186X.2021.1973679

Year: 2021

CSF Biomarkers in Patients With COVID-19 and Neurologic Symptoms

DOI: 10.1212/WNL.0000000000010977

Year: 2021

Etiology of Clinical Community-Acquired Pneumonia in Swedish Children Aged 1–59 Months with High Pneumococcal Vaccine Coverage—The TREND Study

DOI: 10.3390/vaccines9040384

Year: 2021

CLEP_A_312742 649..659

DOI:

Year: 2021

Incidence and Severity of Covid-19 in Patients with and without Previously Verified Infections with Common Cold Coronaviruses

DOI: 10.1093/infdis/jiab089

Year: 2021

Recurrent and persistent infection with SARS-CoV-2 – epidemiological data and case reports from Western Sweden, 2020

DOI: 10.1080/23744235.2021.1957143

Year: 2021

Viral interference cannot be concluded from datasets containing only symptomatic patients

DOI: 10.1016/S2666-5247(20)30219-6

Year: 2021

How Do MHC Genes Influence Immune Response?

How to Interpret Chest CT Scan Results?

Can Symptomatic Relief Replace Primary Treatment?

What is Insect Repellent?

What are the Risk Factors for Developing Dengue Hemorrhagic Fever?

How Do Antipyretics Affect the Course of Infectious Diseases?

What are the Risks of Untreated Infections During Pregnancy?

How is Drug Toxicity Measured?

What is a Drug Target?

What is Genomics?

Partnered Content Networks

Relevant Topics